name: Guidance for drainage and placement of chest tube of Pleural space


name: Guidance for injection of Spine epidural space


name: Guidance for injection of Temporomandibular joint


name: Guidance for kyphoplasty of Thoracic spine


name: Guidance for percutaneous biopsy of Kidney


name: HEDIS 2020 Value Set - Urine Protein Tests


name: HEDIS 2020 Value Set - Urine Protein Tests:-:Pt:^Patient:-


name: Home accessibility evaluation status:Find:Pt:^Patient:Nom


name: Home accessibility modification panel:-:Pt:^Patient:-


name: Home accessibility modification responsible party:Find:Pt:^Patient:Nom


name: Home accessibility modification responsible party


name: HEDIS 2020 Value Set - BMI:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - BMI percentile:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - CT Colonography:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - Diastolic Blood Pressure:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - Diastolic Blood Pressure


name: HEDIS 2020 Value Set - Systolic Blood Pressure:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - Systolic Blood Pressure


name: Setting of exposure to environmental or occupational hazard:Type:Pt:^Patient:Nom


name: Lifetime risk for developing coronary heart disease based on genetic risk score:Likelihood:Lifetime:^Patient:Ord


name: Somatic symptom disorder severity:Imp:Pt:^Patient:Ord


name: Substance use disorder question consistency score:Score:Pt:^Patient:Qn


name: Substance use disorder score:Score:Pt:^Patient:Qn


name: Medical records in response to authorization denial


name: Medical records in response to authorization denial:Find:Pt:^Patient:Doc


name: Substance use disorder severity:Imp:Pt:^Patient:Ord


name: Insertion of composite restoration using strip crown


name: Healthy Eating Index 2015 (assessment scale)


name: Monocyte chemotactic protein-2 measurement


name: Discharge/discontinuation of the episode of care documented in the medical record (M1009)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1012)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1014)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1011)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1010)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1013)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1015)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1112)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1107)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1122)


name: The start of an episode of care documented in the medical record (M1135)


name: The start of an episode of care documented in the medical record (M1111)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1137)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1117)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1127)


name: The start of an episode of care documented in the medical record (M1121)


name: The start of an episode of care documented in the medical record (M1106)


name: The start of an episode of care documented in the medical record (M1136)


name: The start of an episode of care documented in the medical record (M1116)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1131)


name: The start of an episode of care documented in the medical record (M1126)


name: Was Menopausal Hormone Therapy Ever Used


name: Was another Form of Birth Control Ever Used


name: Have Oral Contraceptives Ever Been Taken


name: Date and Method of Initial Pathologic Diagnosis


name: Date of Tumor Progression After Initial Treatment


name: Date of Tumor Reoccurrence After Initial Treatment


name: Did the Individual have Multiple Known Primary Tumors at Initial Melanoma Diagnosis


name: What is the First Course Treatment Completion Measure of Success of Outcome


name: Did a New Event Occur After Initial Treatment


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Additional Surgery for New Tumor Event Loco-Regional


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Additional Surgery for New Tumor Event Metastasis


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Tumor Progression after Initial Treatment


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Tumor Reoccurrence After Initial Treatment


name: Number of Discontiguous Lesions (New Tumor Event)


name: Number of Known Primaries at the Time of Initial Melanoma Diagnosis


name: Number of Other Lymph Nodes Positive for Tumor by H&E


name: Number of Other Lymph Nodes Positive for Tumor by IHC staining only


name: Number of Para-aortic Lymph Nodes Examined


name: Number of Para-aortic Lymph Nodes Positive for Tumor by H&E


name: Number of Para-aortic Lymph Nodes Positive for Tumor by IHC Staining Only


name: Number of Pelvic Lymph Nodes Positive for Tumor by H&E


name: Number of Pelvic Lymph Nodes Positive for Tumor by IHC staining only


name: Were Immunophenotype and Cytochemistry Analyses Performed on Bone Marrow Aspirate


name: Number of Primary Tumors in this Location


name: Was Adjuvant Post-operative Radiation Therapy Administered


name: Was Adjuvant Post-Operative Chemotherapy Administered


name: Was Adjuvant Post-Operative Hormone Therapy Administered


name: Was Adjuvant Post-Operative Immunological Therapy Administered


name: Was Adjuvant Post-Operative Pharmaceutical Therapy Administered


name: Was Adjuvant Post-Operative Targeted Molecular Therapy Administered


name: Brimonidine Tartrate Nanoemulsion OCU-300


name: What is the Other Performance Status Scale: Timing


name: What is the Follow-Up Form Completion Outcome Measure of Success


name: Specify Other Performance Status Scale: Timing


name: What is the Procedure Type for New Tumor Event


name: Other Procedure Type for New Tumor Event


name: What is the Status of the Residual Tumor After Surgery for New Tumor Event


name: Was Additional Treatment Administered for New Tumor Event


name: Were Immunophenotype and Cytochemistry Analyses Performed on Peripheral Blood Samples


name: Bone Marrow Aspirate Immunophenotype & Cytochemistry


name: Peripheral Blood Immunophenotype & Cytochemistry


name: Well-Differentiated or De-Differentiated New Tumor


name: Diagnostic Evidence of Recurrence/Relapse


name: Type of New Melanoma Related Tumor Event


name: Did the Individual use Smokeless Tobacco Use at Diagnosis


name: Regular Smokeless Tobacco Use for Six Weeks or More


name: Average Daily Use Smokeless Tobacco after Use for Six Weeks


name: Age When Quit using Smokeless Tobacco after Regular Use


name: Was Evidence of Disease Present after Completion of Therapy


name: Was Tumor Progression Present After Initial Treatment


name: Was Tumor Reoccurrence Present After Initial Treatment


name: Were Local Anesthesia Agents Administered


name: Alcohol-free Hypoallergenic Barrier Film Solution


name: Postmenopausal with no Prior Oophorectomy Status


name: Primary Site of New Non-Melanoma Tumor Event


name: Histological Type of New Non-Melanoma Tumor Event


name: Site of New Distant Metastasis Tumor Event


name: Specify Molecular Abnormalities in Study


name: Days to Absolute Neutrophil Count Greater than 1000 per Microliter


name: Days to Platelet Count Greater than 100,000 per Microliter


name: del(10q23)/PTEN Gene Locus Deletion Analysis


name: del(10q23)/PTEN Gene Locus Deletion Analysis Method


name: EGFR Amplification Analysis Testing Method


name: Percent Blasts in Peripheral Blood at Diagnosis


name: Complete Blood Count from Clinical Peripheral Blood (Within 24 Hours of Banking)


name: Specify Other ERBB2 Non-Exon 20 Mutation


name: MGMT Promoter Methylation Testing Method


name: Is Another Non-Exon 20 ERBB2 Mutation Present


name: Specify Molecular Abnormality Analysis Method


name: SDH Complex Mutation Analysis Testing Method


name: Did Caregiving Responsibilities Make it Difficult to Work the Required Number of Job Hours


name: Did Caregiving Responsibilities Make it Difficult to Get Going Easily at Beginning of Workday


name: Did Caregiving Responsibilities Make it Difficult to Start Job on Arrival at Work


name: Did Caregiving Responsibilities Make it Difficult to do Work Without Stopping For Breaks or Rests


name: Did Caregiving Responsibilities Make it Difficult to Stick to Job Routine or Schedule


name: Have Difficulty with Sitting, Standing, or Staying in One Position Longer than 15 Minutes While Working Due to Caregiving Responsibilities


name: Have Difficulty Repeating Same Motions Repeatedly While Working Due to Caregiving Responsibilities


name: Did Caregiving Responsibilities Make it Difficult to Keep Mind on Work


name: Did Caregiving Responsibilities Make it Difficult to Do Work Carefully


name: Did Caregiving Responsibilities Make it Difficult to Think Clearly When Working


name: Did Caregiving Responsibilities Make it Difficult to Concentrate on Work


name: Did Caregiving Responsibilities Make it Difficult to Work Without Losing Train of Thought


name: Did Caregiving Responsibilities Make it Difficult to Easily Read or Use Eyes When Working


name: Did Caregiving Responsibilities Make it Difficult to Speak With People In-Person, in Meetings, or Phone When Working


name: Did Caregiving Responsibilities Make it Difficult to Control Temper Around People When Working


name: Did Caregiving Responsibilities Make it Difficult to Help Other People to Get Work Done


name: Did Caregiving Responsibilities Make it Difficult to Listen Well to New Information Given at Work


name: Did Caregiving Responsibilities Make it Difficult to Control Feelings of Sadness or Grief When Working


name: Did Caregiving Responsibilities Make it Difficult to Handle Workload


name: Did Caregiving Responsibilities Make it Difficult to Work Fast Enough


name: Did Caregiving Responsibilities Make it Difficult to Finish Work on Time


name: Did Caregiving Responsibilities Make it Difficult to Do Work Without Making Mistakes


name: Did Caregiving Responsibilities Make it Difficult to Feel You've Done What You're Capable of Doing


name: Have Difficulty Doing Usual Household Chore or Activity Because of Caregiving Responsibilities


name: Someone There for Suggestions About How to Deal with Personal Problem


name: Someone There to Love and Make You Feel Wanted


name: Someone There to Get Together for Relaxation


name: Someone There to Help With Daily Chores if Sick


name: Someone There to Perform Caregiving Responsibilities When You Cannot


name: Someone There for Questions or Concerns About Caregiving


name: Being Able to Provide Assistance as Caregiver is Emotionally Rewarding for Me


name: Being Able to Provide Assistance as Caregiver is Spiritually Rewarding for Me


name: Being Able to Provide Assistance as Caregiver Helps Me Feel in Control of Situation


name: Being Able to Provide Assistance as Caregiver is Important to Me


name: Being Able to Provide Assistance as Caregiver is My Duty as Responsible Adult


name: Currently Paying Someone to Assist with Caregiving


name: Plan to Take Leave of Absence From Work Over Next Year Because of Caregiving


name: Was Interferon Gamma Treatment Administered Prior to Specimen Resection


name: Was Interferon Gamma Treatment Administered 90 Days Prior to Specimen Resection


name: Description of Epochs of O2 Desaturation Less than 92% Greater than 5 Minutes Prior to Organ Excision


name: Intraoperative Blood Product Administration


name: Were Other Medications Administered During Surgery


name: Were Steroids Administered During Surgery


name: Other Medications Administered During Surgery Prior to Tumor Tissue Removal


name: Surgery Information Indicate If any of the Following Medications were Administered During Surgery


name: Specify Other Muscle Relaxants Administered


name: Specify Other Narcotics or Opiates Administered


name: Were Other Preoperative IV Medications Administered


name: Were Preoperative IV Antacids Administered


name: Were Preoperative IV Antiemetics Administered


name: Were Preoperative IV Opiates Administered


name: Specify Other Preoperative IV Sedation Administered


name: Was Preoperative IV Sedation Administered


name: Highest Grade Pancreatic Intraepithelial Neoplasia


name: Which Pulmonary Function Tests Were Performed


name: Pathologic Findings in Non-Neoplastic Kidney


name: Prognostic Features Used for Tumor Prognosis


name: Renal Vein or Vena Cava Thrombosis or Other Coagulopathies


name: CPTAC Acute Myeloid Leukemia Baseline Form


name: Prepare and Give Medicines, Fluids, Nutrition Intravenously


name: Prepare and Give Medicine as Shot in Muscle or Under Skin


name: Change Dressing on Your Child's Catheter and Change Catheter Cap


name: Manage Child's Side Effects of Cancer or its Treatment


name: Keep Your Child Comfortable and Without Pain


name: Manage Other Childhood Illnesses for Your Child with Cancer


name: Manage Unexpected Events Related to Your Child's Illness


name: Additional Household Tasks Related to Your Child's Illness


name: Coordinate, Arrange, and Manage Child's Medical Services


name: Travel to and From Hospital for Medical Care


name: How Much Time Spent at Hospital for Appointments


name: How Much Effort or Difficulty for Time Spent at Hospital for Appointments


name: Provide Emotional Support for Your Child with Cancer


name: Provide Emotional Support for Other Children in the Family


name: Provide Emotional Support for Extended Family


name: Comfort Your Child Through Pain of Cancer and its Treatment


name: Take Care of Discipline and/or Behavior Problems of Child with Cancer


name: Take Care of Finances, Bills, and Forms Related to Child's Illness


name: Plan Activities for Your Child with Cancer Around Treatment and Illness


name: Plan Activities for Your Family Around Treatment and Illness


name: Get Child Care or Babysitting Help for Your Ill Child


name: Get Child Care or Babysitting for Siblings of Ill Child


name: Communicate Information About Cancer to Schools, Day Care, Babysitters, Extended Family, and Friends


name: Watch for and Report Your Child's Physical Symptoms and Medical Condition to Medical Team


name: Get Information on Your Child's Illness and Treatment


name: Anything Else You Wish to Tell About Taking Care of Your Child with Cancer


name: CPTAC Uterine Corpus Endometrial Carcinoma Baseline Form


name: CPTAC Lung Squamous Cell Carcinoma and Lung Adenocarcinoma Baseline Form


name: CPTAC Clear Cell Renal Cell Carcinoma Baseline Form


name: CPTAC Head and Neck Squamous Cell Carcinoma Baseline Form


name: CPTAC Glioblastoma Multiforme Baseline Form


name: Regimen Used to Treat Malignant Thymus Neoplasm


name: Regimen Used to Treat Malignant Anal Neoplasm


name: Regimen Used to Treat Chronic Myeloid Leukemia


name: Regimen Used to Treat Merkel Cell Carcinoma


name: Regimen Used to Treat Myelodysplastic Syndromes


name: Regimen Used to Treat Hepatobiliary Cancer


name: Regimen Used to Treat Plasma Cell Neoplasm


name: Regimen Used to Treat Primary Amyloidosis


name: Regimen Used to Treat Malignant Soft Tissue Neoplasm


name: Were IV Narcotic/Opiate Agents Administered


name: Radium Ra 224-labeled Calcium Carbonate Microparticles


name: Validated Hemophilia Regimen Treatment Adherence Scale - On-Demand


name: Validated Hemophilia Regimen Treatment Adherence Scale - Prophylaxis


name: Other Site of New Distant Metastasis Tumor Event


name: Was the Individual Exposed to Second-Hand Smoke


name: Specify Other Inhalation Anesthesia Agents


name: Specify Other Preoperative IV Anesthesia Administered


name: Response Evaluation Criteria In Lymphoma 2017


name: Were Additional Molecular Studies Performed


name: Was 10q23/PTEN Locus Deletion Analysis Performed


name: Was IDH Family Mutation Analysis Performed


name: Was Immunohistochemical Testing Performed


name: Was Additional Immunohistochemical Testing Performed


name: Was Additional Mutation Analysis Performed


name: Was MGMT Promoter Methylation Testing Performed


name: Was SDH Complex Mutation Analysis Performed


name: Was Fluorescence In Situ Hybridization Performed


name: Regimen Used to Treat or Prevent Graft Rejection


name: Autologous Stem Cell Transplant Recipient


name: Allogeneic Stem Cell Transplant Recipient


name: modified Severity Weighted Assessment Tool


name: First Visit Year with All Necessary Components to Determine


name: Specify Site If Distant Metastasis Submitted


name: Struggle with Rent or Mortgage Due to Financial Difficulties


name: Live with Others Due to Financial Difficulties


name: Lack of Reliable Transportation Keeps from Appointments, Meetings, Work, or Daily Living


name: Utility Company Threatened to Shut Off Services for not Paying Bills


name: Utility Company Shut Off Services for not Paying Bills


name: Days Home Not Heated or Cooled Because Bills Not Paid


name: Used Cooking Stove to Heat Home Because Bills Not Paid


name: Telephone Service Disconnected Due to Bill Not Paid


name: Worried Food Would Run Out Before Get Money to Buy More


name: Food Bought Didn't Last and Didn't Have Money to Get More


name: If Lose Current Income Sources and Live Off Savings, How Long Could Continue to Live at Current Address and Standard of Living


name: Family Received Food from Food Pantry or Soup Kitchen


name: Family Received Low-Income or Subsidized Housing


name: Family Received Free or Subsidized School Lunch


name: Specify Number of Lymph Nodes Positive for Tumor by IHC Staining Only


name: Specify Number of Lymph Nodes Positive for Tumor by H&E


name: International Myeloma Working Group Minimal Residual Disease Criteria


name: International Myeloma Working Group Standard Response Criteria


name: Have a Regular Morning Routine in Our Home


name: Try to See Humorous Side of Things When Faced with Problems


name: Having to Cope with Stress can Make me Stronger


name: Tend to Bounce Back After Illness, Injury, or Other Hardships


name: Can Achieve my Goals, Even if There are Obstacles


name: Think of Myself as a Strong Person When Dealing with Life's Challenges and Difficulties


name: Able to Handle Unpleasant or Painful Feelings


name: Treated with Less Courtesy or Respect than Other People


name: Receive Poorer Service Than Other People at Restaurant or Stores


name: People Act as if They Think You are Not Smart


name: Regimen Used to Treat Malignant Bone Marrow Neoplasm


name: Retrograde Selective Washing of Upper Tract


name: Regimen Used to Treat Malignant Intestinal Neoplasm


name: Was a New Tumor Event Present After Initial Treatment


name: Regimen Used to Treat Malignant Fallopian Tube Neoplasm


name: Regimen Used to Treat Malignant Peritoneal Neoplasm


name: Lymphedema Symptom Intensity and Distress Survey - Arm


name: Regimen Used to Treat Malignant Germ Cell Tumor


name: Regimen Used to Treat Malignant Reproductive Endocrine Neoplasm


name: Have Lack of Confidence in Insurance Provider


name: Feel Misunderstood by Spouse or Significant Other


name: Have Inability to Complete Hobbies or Leisure Activities


name: Consistently Decreased Social Activities


name: Symptoms Intensity and Distress Likert Scale


name: Fluorouracil Continuous Infusion Regimen


name: Methotrexate Intra-Cerebrospinal Fluid Regimen


name: Intralesional Interferon Alfa-2b Regimen


name: Talimogene Laherparepvec Intralesional Regimen


name: Rituximab and Hyaluronidase Human Regimen


name: Needed Medical Care or Prescription Medicine but Unable to Afford it


name: Who Needed Medical Care but Family Unable to Afford it


name: Who Needed Prescription Medicine but Family Unable to Afford it


name: Specify Another Form of Birth Control that was Used


name: MLH1 Gene Promoter Hypermethylation Status


name: Was Additional Surgery for New Loco-Regional Tumor Event Performed


name: Was Additional Surgery for New Metastatic Tumor Event Performed


name: Date of Additional Surgery for New Tumor Event: Loco-Regional


name: Date of Additional Surgery for New Tumor Event: Metastatic


name: Antithymocyte Globulin Rabbit/Tacrolimus Regimen


name: Horse Antithymocyte Globulin/Tacrolimus Regimen


name: Rabbit Anti-thymocyte Globulin/Prednisone/Tacrolimus Regimen


name: Equine Anti-thymocyte Globulin/Prednisone/Tacrolimus Regimen


name: Dose-adjusted R-EPOCH Plus High-dose Methotrexate Regimen


name: R-CODOX-M Alternating with R-IVAC Regimen


name: Was ALK Rearrangement Analysis Performed


name: Was BRAF Rearrangement Analysis Performed


name: Was RET Rearrangement Analysis Performed


name: Was ROS1 Rearrangement Analysis Performed


name: Tissue Expander-Implant Breast Reconstruction


name: Was Radiation Administered as an Additional Treatment for a New Tumor Event


name: Was Chemotherapy Administered as an Additional Treatment for a New Tumor Event


name: Was Immunotherapy Administered as an Additional Treatment for a New Tumor Event


name: Was Hormone Therapy Administered as an Additional Treatment for a New Tumor Event


name: Was Targeted Molecular Therapy Administered as an Additional Treatment for a New Tumor Event


name: Was Additional Pharmaceutical Treatment for New Tumor Event Administered


name: Number of Days from Date of Collection to Date of Last Contact


name: Was Bone Marrow Transplantation Performed


name: Specify if Other Cytogenetic Analysis Abnormality Type


name: Discrete Set Telecommunication URL Data Type


name: Regimen Used to Treat Non-neoplastic Hematologic Disorders


name: Are Tumor Infiltrating Lymphocytes Present


name: Test of Word Reading Efficiency, Second Edition


name: Oral Mechanism/Cranial Nerve Examination for Young Children


name: Head and Neck Survivorship Tool: Assessment and Recommendations


name: Computed Spanish/Hispanic Ethnicity Code


name: CDISC Protocol Study Population Attribute Terminology


name: CDISC SDTM Laboratory Analytical Method Calculation Formula Terminology


name: CDISC SDTM Model Version ResponseTerminology


name: CDISC SDTM Implementation Guide Version Response Terminology


name: CDISC Therapeutic Area User Guide Response Terminology


name: CDISC SDTM FDA Technical Specification Response Terminology


name: CDISC SEND Body Irradiation Model Response Terminology


name: CDISC SEND Rad/Nuc Targeted Injury Model Response Terminology


name: CDISC SEND Chemical Challenge Agent Name Response Terminology


name: CDISC SEND Genus and Species Response Terminology


name: Beta-lactamase Positive Bacteria Measurement


name: Beta-lactamase Negative Bacteria Measurement


name: Non-Cogstate Baseline and Follow-up Measures


name: Automated Video-Assisted Smoking Treatment


name: Evidence of Malignant Disease Description


name: CDISC Diabetes Therapeutic Area User Guide Version 1.0 - Supplement for ADaM


name: Robot-Assisted Salvage Pelvic Lymph Node Dissection


name: Robot-assisted Salvage Pelvic Mass Resection


name: Kappa Light Chain to Lambda Light Chain Ratio Measurement


name: Cytochrome P450 2C9 Activity Measurement


name: Progressive Spermatozoa to Total Spermatozoa Ratio Measurement


name: pH Adjusted for Body Temperature Measurement


name: Thyroid Stimulating Immunoglobulin Actual to Control Ratio Measurement


name: APTT-LA Actual to Control Ratio Measurement


name: Thrombin Time Actual to Control Ratio Measurement


name: APTT-LA Screen to Confirm Percent Difference


name: dRVVT Screen to Confirm Percent Difference


name: Choriogonadotropin Adjusted for Maternal Weight Measurement


name: Neisseria gonorrhoeae, Beta-lactamase Positive Measurement


name: Neisseria gonorrhoeae, Beta-lactamase Negative Measurement


name: Multiple Inert Gas Elimination Technique


name: Natural Log Transformed Observed Area Under the Curve Infinity


name: Natural Log Transformed Area Under the Curve From Dosing to Last Concentration


name: CDISC SDTM Implementation Guide Version 3.1.1


name: CDISC SDTM Implementation Guide Version 3.1.2


name: CDISC SDTM Implementation Guide Version 3.1.2 Amendment 1


name: CDISC SDTM Implementation Guide Version 3.1.3


name: CDISC Chronic Hepatitis C Therapeutic Area User Guide Version 1.0


name: CDISC Diabetic Kidney Disease Therapeutic Area User Guide Version 1.0


name: CDISC Duchenne Muscular Dystrophy Therapeutic Area User Guide Version 1.0


name: CDISC Dyslipidemia Therapeutic Area User Guide Version 1.0


name: CDISC Ebola Therapeutic Area User Guide Version 1.0


name: CDISC Influenza Therapeutic Area User Guide Version 1.1


name: CDISC Influenza Therapeutic Area User Guide Version 1.0


name: CDISC Kidney Transplant Therapeutic Area User Guide Version 1.0


name: CDISC Major Depressive Disorder Therapeutic Area User Guide Version 1.0


name: CDISC Malaria Therapeutic Area User Guide Version 1.0


name: CDISC Prostate Cancer Therapeutic Area User Guide Version 1.0


name: CDISC QT Studies Therapeutic Area User Guide Version 1.0


name: CDISC Rheumatoid Arthritis Therapeutic Area User Guide Version 1.0


name: CDISC Schizophrenia Therapeutic Area User Guide Version 1.1


name: CDISC Schizophrenia Therapeutic Area User Guide Version 1.0


name: CDISC Traumatic Brain Injury Therapeutic Area User Guide Version 1.0


name: CDISC Tuberculosis Therapeutic Area User Guide Version 2.0


name: CDISC Vaccines Therapeutic Area User Guide Version 1.1


name: CDISC Virology Therapeutic Area User Guide Version 2.1


name: CDISC Virology Therapeutic Area User Guide Version 2.0


name: CDISC Alzheimer's Therapeutic Area User Guide Version 1.0


name: CDISC Alzheimer's Therapeutic Area User Guide Version 2.0


name: CDISC Asthma Therapeutic Area User Guide Version 1.0


name: CDISC Breast Cancer Therapeutic Area User Guide Version 1.0


name: CDISC Cardiovascular Studies Therapeutic Area User Guide Version 1.0


name: CDISC Colorectal Cancer Therapeutic Area User Guide Version 1.0


name: CDISC COPD Therapeutic Area User Guide Version 1.0


name: CDISC HIV Therapeutic Area User Guide Version 1.0


name: CDISC Huntington's Disease Therapeutic Area User Guide Version 1.0


name: CDISC Multiple Sclerosis Therapeutic Area User Guide Version 1.0


name: CDISC Pain Therapeutic Area User Guide Version 1.0


name: CDISC Pain Therapeutic Area User Guide Version 1.1


name: CDISC Parkinson's Disease Therapeutic Area User Guide Version 1.0


name: CDISC Polycystic Kidney Disease (PKD) Therapeutic Area User Guide Version 1.0


name: CDISC Post Traumatic Stress Disorder Therapeutic Area User Guide Version 1.0


name: US FDA HIV Technical Specifications Guidance v1.0


name: US FDA Vaccines Technical Specification Guidance v1.0


name: US FDA Clinical Endpoint BE Studies v1.0


name: US FDA Study Data Technical Conformance Guide v4.2.1


name: Expected Onset of Rad/Nuc Targeted Injury


name: Chemical Agent Material Identification Code


name: Total Body Irradiation Plus Bone Marrow Transplant


name: Total Body Irradiation with Bone Marrow Not Irradiated


name: Bio-enhanced Curcumin Extract Formulation


name: CDISC Questionnaire EORTC QLQ-C15-PAL Version 1 Test Name Terminology


name: CDISC Questionnaire EORTC QLQ-C15-PAL Version 1 Test Code Terminology


name: CDISC Questionnaire EORTC QLQ-C30 Version 3 Test Name Terminology


name: CDISC Questionnaire EORTC QLQ-C30 Version 3 Test Code Terminology


name: CDISC Questionnaire T1-DDS Test Name Terminology


name: CDISC Questionnaire T1-DDS Test Code Terminology


name: CDISC Clinical Classification AVPU Test Name Terminology


name: CDISC Clinical Classification AVPU Test Code Terminology


name: CDISC Clinical Classification BPRS 1988 Version Test Name Terminology


name: CDISC Clinical Classification BPRS 1988 Version Test Code Terminology


name: CDISC Clinical Classification E-TRIP Test Name Terminology


name: CDISC Clinical Classification E-TRIP Test Code Terminology


name: EORTC QLQ-C15-PAL Version 1 Questionnaire Question


name: EORTC QLQ-C30 Version 3 Questionnaire Question


name: BPRS 1988 Version Clinical Classification Question


name: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Paliative Care Version 1.0


name: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0


name: Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire


name: Alert Verbal Painful Unresponsive Scale Clinical Classification


name: Brief Psychiatric Rating Scale 1988 Version Clinical Classification


name: Emory Treatment Resistance Interview for PTSD Clinical Classification


name: EORTC QLQ-C15-PAL Version 1 - Trouble Taking Short Walk Outside


name: EORTC QLQ-C15-PAL Version 1 - Stay in Bed or Chair During the Day


name: EORTC QLQ-C15-PAL Version 1 - Need Help Eating, Dressing, Washing


name: EORTC QLQ-C15-PAL Version 1 - Were You Short of Breath


name: EORTC QLQ-C15-PAL Version 1 - Have You Had Pain


name: EORTC QLQ-C15-PAL Version 1 - Have You Had Trouble Sleeping


name: EORTC QLQ-C15-PAL Version 1 - Have You Lacked Appetite


name: EORTC QLQ-C15-PAL Version 1 - Have You Felt Nauseated


name: EORTC QLQ-C15-PAL Version 1 - Have You Been Constipated


name: EORTC QLQ-C15-PAL Version 1 - Were You Tired


name: EORTC QLQ-C15-PAL Version 1 - Pain Interfere Daily Activities


name: EORTC QLQ-C15-PAL Version 1 - Did You Feel Tense


name: EORTC QLQ-C15-PAL Version 1 - Did You Feel Depressed


name: EORTC QLQ-C15-PAL Version 1 - Rate Your Overall Quality of Life


name: EORTC QLQ-C30 Version 3 - Trouble Doing Strenuous Activities


name: EORTC QLQ-C30 Version 3 - Trouble Taking Long Walk


name: EORTC QLQ-C30 Version 3 - Trouble Taking Short Walk Outside


name: EORTC QLQ-C30 Version 3 - Stay in Bed or Chair During the Day


name: EORTC QLQ-C30 Version 3 - Need Help Eating, Dressing, Washing


name: EORTC QLQ-C30 Version 3 - Limited in Work or Daily Activities


name: EORTC QLQ-C30 Version 3 - Limited Hobbies or Leisure Activities


name: EORTC QLQ-C30 Version 3 - Were You Short of Breath


name: EORTC QLQ-C30 Version 3 - Have You Had Pain


name: EORTC QLQ-C30 Version 3 - Did You Need to Rest


name: EORTC QLQ-C30 Version 3 - Have You Had Trouble Sleeping


name: EORTC QLQ-C30 Version 3 - Have You Felt Weak


name: EORTC QLQ-C30 Version 3 - Have You Lacked Appetite


name: EORTC QLQ-C30 Version 3 - Have You Felt Nauseated


name: EORTC QLQ-C30 Version 3 - Have You Vomited


name: EORTC QLQ-C30 Version 3 - Have You Been Constipated


name: EORTC QLQ-C30 Version 3 - Have You Had Diarrhea


name: EORTC QLQ-C30 Version 3 - Were You Tired


name: EORTC QLQ-C30 Version 3 - Pain Interfere Daily Activities


name: EORTC QLQ-C30 Version 3 - Difficulty Concentrating on Things


name: EORTC QLQ-C30 Version 3 - Did You Feel Tense


name: EORTC QLQ-C30 Version 3 - Did You Feel Irritable


name: EORTC QLQ-C30 Version 3 - Did You Feel Depressed


name: EORTC QLQ-C30 Version 3 - Had Difficulty Remembering Things


name: EORTC QLQ-C30 Version 3 - Condition Interfered Family Life


name: EORTC QLQ-C30 Version 3 - Condition Interfered Social Activities


name: EORTC QLQ-C30 Version 3 - Rate Your Overall Health


name: EORTC QLQ-C30 Version 3 - Rate Your Overall Quality of Life


name: T1-DDS - Not Skilled at Managing Diabetes


name: T1-DDS - I Don't Eat Carefully as I Should


name: T1-DDS - Don't Notice Signs of Hypoglycemia


name: T1-DDS - Discouraged See High Blood Glucose


name: T1-DDS - Family Make Bigger Deal Diabetes


name: T1-DDS - Can't Tell Doctor What on My Mind


name: T1-DDS - Too Much Diabetes Equipment With Me


name: T1-DDS - Family Worry About Hypoglycemia


name: T1-DDS - Don't Check Glucose as I Should


name: T1-DDS - Food and Eating Control My Life


name: T1-DDS - Family Act Like Diabetes Police


name: T1-DDS - Be Perfect With Diabetes Management


name: T1-DDS - Hypoglycemic Event While Driving


name: T1-DDS - Subscale 2: Management Distress


name: T1-DDS - Subscale 3: Hypoglycemia Distress


name: T1-DDS - Subscale 4: Negative Social Perceptions


name: T1-DDS - Subscale 7: Friend/Family Distress


name: BPRS 1988 Version - Emotional Withdrawal


name: BPRS 1988 Version - Conceptual Disorganization


name: BPRS 1988 Version - Mannerisms and Posturing


name: BPRS 1988 Version - Hallucinatory Behavior


name: BPRS 1988 Version - Unusual Thought Content


name: Basic Reversed-Phase Liquid Chromatography


name: pH 7.5 Basic Reversed-Phase Liquid Chromatography


name: 2-Dimensional Reversed-Phase Liquid Chromatography


name: Peripheral T-cell Lymphoma Prognostic Index Score


name: Immobilized Metal Affinity Chromatography with Phosphopeptide Enrichment


name: 14-N/15-N Metabolic Labeling Quantification


name: Selected Reaction Monitoring Quantification


name: Label-free Protein Quantification by LC/MS


name: Label-Free Peptide Level Quantification by LC/MS


name: Label-Free Protein Group Level Quantification by LC/MS


name: Label-Free Raw Feature Quantification by LC/MS


name: Label-Free Gene Level Quantification by LC/MS


name: Allogeneic Bone Marrow Transplantation Recipient


name: Autologous Bone Marrow Transplantation Recipient


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Group Identifier


name: Ophthalmic Examinations Group Identifier


name: Urinary System Findings Group Identifier


name: Cardiovascular System Findings Link Identifier


name: Microbiology Susceptibility Link Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Link Identifier


name: Reproductive System Findings Link Identifier


name: Microbiology Specimen Link Group Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Link Group Identifier


name: Reproductive System Findings Link Group Identifier


name: Tumor Identification Link Group Identifier


name: Urinary System Findings Link Group Identifier


name: Cardiovascular System Findings Link Group


name: Solid Dispersion Immediate Release Tablet Dosage Form


name: Cardiovascular System Findings Reference Identifier


name: Functional Tests Sponsor-Defined Identifier


name: Microbiology Specimen Focus of Study-Specific Interest


name: Microbiology Specimen Measurement, Test or Examination Detail


name: Microbiology Susceptibility Non-host Organism Identifier


name: Microbiology Susceptibility Measurement, Test or Examination Detail


name: Microbiology Susceptibility Modified Reported Name


name: Microbiology Susceptibility External File Path


name: Microbiology Susceptibility Analysis Method


name: Microbiology Susceptibility Collected Duration


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Sponsor-Defined Identifier


name: Nervous System Sponsor-Defined Identifier


name: Urinary System Findings Sponsor-Defined Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Elapsed Time


name: Reproductive System Findings Elapsed Time


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Reference Identifier


name: Respiratory System Findings Reference Identifier


name: Urinary System Findings Reference Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Time Point Reference


name: Ophthalmic Examinations Time Point Reference


name: Reproductive System Findings Time Point Reference


name: Powder and Solution for Suspension for Injection


name: Proton Multiple Quantum Coherence Magnetic Resonance Spectroscopic Imaging


name: Ophthalmic Examinations External File Path


name: Urinary System Findings Time Point Reference


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Completion Status


name: Nervous System Findings Completion Status


name: Ophthalmic Examinations Completion Status


name: Ophthalmic Examinations Normal or Reference Range Indicator


name: Microbiology Susceptibility Normal or Reference Range Indicator


name: Microbiology Susceptibility Specimen Type


name: Microbiology Susceptibility Agent Concentration Unit


name: Spectral Domain-Optical Coherence Tomography


name: Recombinant Human Plasminogen Kringle 5 Domain ABT 828


name: Protein Expression Analysis by Immunohistochemistry


name: Bone Marrow Differential Count within 24 Hours of Banking


name: Navigated Transcranial Magnetic Stimulation


name: Whole Abdominopelvic Intensity-Modulated Radiotherapy


name: Behavioral Activation Intervention to Smoking Cessation and to Post-Cessation Weight Gain


name: Principal Statistical Analysis Plan Version


name: Statistical Analysis Plan Document Version


name: Specify Other Preoperative IV Antacids Administered


name: Specify Other Preoperative IV Antiemetics Administered


name: Revised International Prognostic Scoring System


name: Specify Other Spinal/Epidural Anesthesia Agents Administered


name: Montreal Cognitive Assessment Visuospatial/Executive Test


name: Montreal Cognitive Assessment Attention - Digits Test


name: Montreal Cognitive Assessment Attention - Letters Test


name: Montreal Cognitive Assessment Attention - Subtraction Test


name: Montreal Cognitive Assessment Language - Repeat Test


name: Montreal Cognitive Assessment Language - Fluency Test


name: Montreal Cognitive Assessment Delayed Recall Test


name: Beclomethasone Dipropionate/Formoterol Fumarate Inhalation Solution


name: Submicron Particle Paclitaxel Sterile Suspension


name: BardPort Titanium Implanted Port with Peritoneal Catheter


name: Immune Effector Encephalopathy - ICE Assessment


name: INC Demographic and Maternal Terminology


name: Date of Neonatal Intensive Care Unit Admission


name: Mortality Cut-off Year, National Death Index


name: Stay Focused and Think Clearly Under Pressure


name: CDISC SEND Expected Onset of Rad/Nuc Targeted Injury Response Terminology


name: Fructosamine Corrected for Total Protein Measurement


name: Planned Challenge Agent Exposure Frequency


name: EORTC QLQ-C15-PAL Version 1 - Have You Felt Weak


name: EORTC QLQ-C30 Version 3 - Condition Caused Financial Difficulties


name: T1-DDS - Be Safe From Hypoglycemic Event


name: pH 10 Basic Reversed-Phase Liquid Chromatography


name: Nervous System Findings Group Identifier


name: Bifidobacterium longum/Lactobacillus acidophilus/Enterococcus faecalis Probiotic Supplement


name: Were Subsequent Known Primary Melanoma(s) Found During the Follow-Up


name: Cytogenetic Risk Group-CALGB Criteria for AML


name: ANHYDROUS CITRIC ACID 166 mg in 270 mL INTRAVENOUS INJECTION, SOLUTION [Citric Buffered Normal Saline]


name: CellPad Medical Grade Silicone Gel Matrix (Large)


name: Ensure Plant-Based Protein Nutrition Shake (Chocolate)


name: Ensure Plant-Based Protein Nutrition Shake (Vanilla)


name: Emergen-C Electrolyte Replenisher Powder for Solution (Lemon-Lime)


name: LEVOMEFOLATE CALCIUM 15 mg ORAL CAPSULE [Denovo]


name: menaquinone 500 mcg-100 mcg oral capsule


name: One Touch Ultra2 Syst 024-046 blood glucose m


name: Onetouch Delica Plus Lancing Device 023-973


name: PediaSure Peptide 1.0 Cal Liquid Strawberry


name: PediaSure Peptide 1.0 Cal Liquid Unflavored


name: Similac Advance Lamehadrin Infant Formula


name: Similac Go & Grow HMO Toddler Drink Powder Un


name: PediaSure Peptide 1.0 Cal Liquid Vanilla


name: PediaSure Peptide 1.5 Cal Liquid Vanilla


name: PediaSure with Fiber 1.0 Cal Liquid Vanilla


name: PediaSure with Fiber 1.5 Cal Liquid Vanilla


name: Contact Lens Product Ophthalmic Solution [SALINE SOLUTION]


name: Ointment, Multi Ingredient Topical application Ointment [AVEENO REPAIRING CICA HAND MASK]


name: Ointment, Multi Ingredient Topical application Ointment [AVEENO REPAIRING CICA FOOT MASK]


name: Pyridoxal Phosphate 100 MG/1 GM Oral Powder [VB6 P5P]


name: Gel, Multi Ingredient Topical application Gel/Jelly [COPADERM]


name: Cleanser Topical application Soap [AVEENO POSITIVELY RADIANT BRIGHTENING DAILY SCRUB]


name: Pyridoxal Phosphate 100 MG/1 GM Oral Powder


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 5.5 g in 100 mL / OXYBENZONE 5 g in 100 mL TOPICAL LOTION [Mary Kay Suncare SPF 50 Sunscreen]


name: Luster Premium White Pro Light Dental Whitening System KIT


name: ZINC OXIDE 44 mg in 1 mL / TITANIUM DIOXIDE 44 mg in 1 mL TOPICAL LOTION [Australian Gold Botanical Sunscreen Tinted Face 50 for Rich to Deep skin tones]


name: ZINC OXIDE 43.2 mg in 1 mL / TITANIUM DIOXIDE 43.2 mg in 1 mL TOPICAL LOTION [Australian Gold Botanical Sunscreen Tinted Face 50 for Fair to Light skin tones]


name: Blistex Advanced Care (Blistex Medicated Balm, Blistex Complete Moisture, Blistex Five Star Lip Balm - Broad Spectrum, Blistex Superfruit Soother) KIT


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL SPRAY [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 80 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 80 mg in 1 g TOPICAL SPRAY [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 9 g in 100 g TOPICAL CREAM [Olay Regenerist Whip Active Moisturizer Broad Spectrum SPF 40 Sunscreen]


name: ALUMINUM SESQUICHLOROHYDRATE 17.6 g in 100 g TOPICAL AEROSOL, SPRAY [Degree]


name: LEVAMISOLE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: OXYBENZONE 3 g in 100 mL / OCTOCRYLENE 1.86 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / AVOBENZONE 2 g in 100 mL TOPICAL LOTION [Glytone Daily Body]


name: TOLAZOLINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: CEFPODOXIME PROXETIL 1 g in 1 g NOT APPLICABLE POWDER


name: ZINC OXIDE 5.6695 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4.5 g in 100 g / HOMOSALATE 6 g in 100 g TOPICAL LOTION [Hawaiian Tropic Matte Effect Mineral Enriched Sunscreen SPF 30]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Candy 1]


name: ZINC OXIDE 11 g in 100 mL / TITANIUM DIOXIDE 8 g in 100 mL TOPICAL LOTION [MOOR SPA SPF30 Sunscreen]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 159 mg in 1 g TOPICAL STICK [Lady Speed Stick Invisible Dry Power Spring Blossom - antiperspirant/deodorant]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Dolce Vita]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OXYBENZONE 40 mg in 1 g TOPICAL STICK [Softlips Oasis Pineapple Coconut, Peach Mango, Strawberry Kiwi]


name: TEMOZOLOMIDE 1 g in 1 g NOT APPLICABLE POWDER


name: BUTYLSCOPOLAMINE BROMIDE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 30 mg in 1 mL / TITANIUM DIOXIDE 17.5 mg in 1 mL TOPICAL CREAM [TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 N365]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Teen Be Positive]


name: Avobenzone 30 mg in 1 mL / Homosalate 100 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 50 mg in 1 mL / Oxybenzone 60 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios 50 Daily Antiaging Primer with Sunscreen]


name: FAK Care4 Bus and School Yellow ORM D KIT


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Soft Creme]


name: Avobenzone/Octisalate/Octocrylene 3%-5%-10% Topical application Cream [GOLD BOND ULTIMATE NECK & CHEST AGE DEFENSE]


name: ALUMINUM CHLOROHYDRATE 220 mg in 1 g TOPICAL STICK [Toms of Maine Coconut Lavender Antiperspriant / Deodorant]


name: ZINC OXIDE 83.4 mg in 1 g / TITANIUM DIOXIDE 10 mg in 1 g TOPICAL GEL [Blue Lizard Sensitive Face Sunscreen]


name: HYDROXYETHYL CELLULOSE (140 CPS AT 5%) 3.84 g in 240 mL TOPICAL OIL [WeDol Water-based personal lubricant]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Sport Energy Men]


name: Niacinamide 0.60 g in 30 g / Adenosine 0.01 g in 30 g TOPICAL PATCH [Hyalu Plus Up Mask]


name: Niacinamide 0.60 g in 30 mL / Adenosine 0.01 g in 30 mL TOPICAL LIQUID [VIRGIN GRACE Hyalu Plus Serum]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Elements Canyon]


name: ALUMINUM CHLOROHYDRATE 220 mg in 1 g TOPICAL STICK [Toms of Maine for Men North Woods Antiperspriant Deodorant]


name: {1 (22 ML) (salicylic acid 0.02 MG/MG Topical Gel) / 1 (100 ML) (salicylic acid 10 MG/ML Medicated Liquid Soap) / 1 (50 ML) (salicylic acid 20 MG/ML Topical Lotion) } Pack


name: OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [NuHydraShield 30 SPF-30 Sunscreen]


name: ZINC OXIDE 2.8 mg in 30 mL / TITANIUM DIOXIDE 4.3 mg in 30 mL TOPICAL LIQUID [Revlon Youth FX]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Country]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Fresh]


name: ZINC OXIDE 5 g in 100 mL / TITANIUM DIOXIDE 7.5 g in 100 mL TOPICAL LOTION [Mineral SPF 40 Moisturizer]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4.5 g in 100 g TOPICAL CREAM [TimeWise Repair VoluFirm Day Cream SPF 30 Broad Spectrum Sunscreen]


name: ZINC OXIDE 210 mg in 1 g TOPICAL CREAM [Prevention Plus Daily Tinted Moisturizer SPF 30]


name: Dimethicone;Triamcinolone Acetonide 5%; 0.1% Topical application Cream [TRIVIX]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Secret with Essential Oils Coconut Oil and Mandarin Invisible]


name: AVOBENZONE 1.5 g in 1 g / OCTISALATE 2.5 g in 1 g / OCTOCRYLENE 3.75 g in 1 g TOPICAL CREAM [No7 Early Defence Glow Activating Day Cream]


name: ASCORBIC ACID 125 mg / CHOLECALCIFEROL 0.0125 mg / THIAMINE 1.4 mg / PYRIDOXAL PHOSPHATE ANHYDROUS 2.5 mg / FOLIC ACID 1 mg / METHYLCOBALAMIN 1 mg / CALCIUM CARBONATE 200 mg / FERROUS GLUCONATE 13 mg / POTASSIUM IODIDE 0.15 mg ORAL TABLET [Zalvit]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4.5 g in 100 g TOPICAL CREAM [TimeWise Repair Volu-Firm Day Cream SPF 30 Broad Spectrum Sunscreen]


name: OCTINOXATE 49.9 mg in 1 mL TOPICAL EMULSION [Giorgio Armani My Armani to go essence in foundation cushion SPF 23]


name: AVOBENZONE 29.67 mg in 1 mL / OCTISALATE 49.45 mg in 1 mL / OCTOCRYLENE 49.45 mg in 1 mL / HOMOSALATE 98.9 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 50]


name: AVOBENZONE 29.94 mg in 1 mL / OCTISALATE 49.9 mg in 1 mL / OCTOCRYLENE 49.9 mg in 1 mL / HOMOSALATE 74.85 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 30]


name: AVOBENZONE 26.01 mg in 1 mL / HOMOSALATE 130.05 mg in 1 mL / OCTISALATE 43.35 mg in 1 mL / OCTOCRYLENE 86.7 mg in 1 mL TOPICAL SPRAY [Pamana Jack Broad Spectrum SPF 100]


name: AVOBENZONE 29.55 mg in 1 mL / OCTISALATE 49.25 mg in 1 mL / OCTOCRYLENE 49.25 mg in 1 mL / HOMOSALATE 73.875 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 30]


name: AVOBENZONE 16.08 mg in 1 mL / OCTISALATE 40.2 mg in 1 mL / OCTOCRYLENE 16.08 mg in 1 mL TOPICAL SPRAY [Pamana Jack Broad Spectrum SPF 15]


name: AVOBENZONE 19.68 mg in 1 mL / OCTOCRYLENE 19.68 mg in 1 mL TOPICAL LOTION [Panama Jack SPF 8]


name: AVOBENZONE 19.74 mg in 1 mL / OCTISALATE 49.35 mg in 1 mL / OCTOCRYLENE 19.74 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 15]


name: colostomy bag, non-sterile 1 9/16"-2" (12") MISCELL EACH


name: emollient combination no.114 TOPICAL CREAM (GRAM)


name: silver/silicone/foam bandage 4" X 4" TOPICAL BANDAGE


name: clindamycin/benzoyl/octinox/octyl/octocryl/oxyben/titanium 1 %-2.5 %-SPF 50 TOPICAL KIT, GEL AND LOTION


name: clindamycin/octinoxate/octyl salicyl/octocryl/oxybenz/titan 1 %-SPF 50 TOPICAL KIT, GEL AND LOTION


name: diclofenac sodium/menthol/camphor 75 mg-3 %-3 % MISCELL KIT, GEL AND TABLET DELAYED RELEASE


name: kit for the preparation of Tc-99m/sodium oxidronate 3.15 mg INTRAVEN VIAL (EA)


name: cardioplegic solution no.26 (maintenance 4:1)


name: cardioplegic solution no.27 (induction 4:1)


name: cardioplegic solution no.28 (reperfusate 4:1)


name: cardioplegic solution no.29 (maintenance 4:1)


name: cardioplegic solution no.30 (induction 4:1)


name: influenza A virus A/Kansas/14/2017 (H3N2) antigen / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen / influenza B virus B/Colorado/06/2017 antigen / influenza B virus B/Phuket/3073/2013 antigen


name: camphor / menthol / methyl salicylate / methylsulfonylmethane


name: DRESSING,OPTIFOAM SITE 4IN X 4IN #MSC1104


name: CATHETER,INTERMITTENT 12FR FEMALE CURE #CQT12


name: CATHERIZATION SET,FOLEY 14FR BARD #772417


name: CATHETER,INTERMITTENT 12FR LOFRIC HYDRO-KIT COUDE #4251240


name: MASK,AEROSOL ADULT FACE TENT MEDLINE #HCS4630


name: TRACH ANTI-DISCONNECT DEVICE,SHILEY #SSDD


name: TUBING,SUCTION 1/4IN X 6FT COVIDIEN #8888301606


name: BRIEF,PROTECTION PLUS XX-LARGE #MSC23700


name: CATHETER FOLEY 3-WAY 18FR 5ML BARD #70518L


name: DRESSING,OPTIFOAM GENTLE POST-OP 4IN X 8IN #MSC2148


name: CATHETER,INTERMITTENT,GENTLECATH 16FR FEMALE #421574


name: SUCTION TUBE ATTACHMENT DEVICE CARDINAL #501015


name: ADAPTER,NEBULIZER VALVED CAREFUSION #2061


name: LEG BAG STRAP,SPORT,MEDIUM,UROCARE #6343


name: Myocardial late gadolinium enhancement MRI


name: Urinary neutrophil gelatinase-associated lipocalin


name: Percutaneous transhepatic biliary drainage catheter insertion


name: Dental Providers; Dentist, Orofacial Pain


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Gerontological"


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Obesity and Weight Management"


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Oncology"


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Pediatric Critical Care"


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Sports Dietetics"


name: Allopathic & Osteopathic Physicians; Preventive Medicine, Addiction Medicine


name: Radiation Oncology Quality Assurance Information System Software


name: Monitors, Cardiac Ventricular Assist System


name: Implantable Sensor Left Atrial Pressure Monitoring Systems


name: Vented Noninvasive Ventilation Interfaces


name: Non-Vented Noninvasive Ventilation Interfaces


name: Sterilization Process Challenge, Packs, Biological/Chemical


name: Hemostatic Agents, Surgical, Non-Absorbable


name: Orthopedic Fixation Systems, Implantable, Spine, Interbody Fusion


name: Orthopedic Fixation Systems, Implantable, Spine, Thoracolumbar, Interbody Fusion, Synthetic


name: Interbody Fusion Devices, Thoracic Spine


name: Cardiopulmonary Resuscitation Automated Assistance Devices


name: Sterilization Process Challenge Packs, Biological


name: Sterilization Process Challenge Packs, Chemical


name: Programmer/Testers, Implantable Cardiac Circulatory Assist Unit


name: Cardiopulmonary Resuscitation Compression Feedback Devices


name: Nucleic Acid Processors, Replication, Thermal Cycle, Digital Polymerase Chain Reaction


name: Interbody Spinal Fusion Implants, Thoracolumbar


name: Software, Information Systems, Healthcare Facility, Clinical, Radiotherapy, Quality Assurance


name: Monitoring Systems, Physiologic, Left Atrial Pressure, Telemetric, Implantable Sensor


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Oronasal


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Nasal


name: Analyzers, Physiologic, Cardiovascular Function, Flow-Mediated Skin Fluorescence


name: Simulators, Training, Extracorporeal Membrane Oxygenation


name: IVD Panels, Human Genetics, Encephalopathy, Brain Malformation, Septo-Optic Dysplasia


name: IVD Panels, Human Genetics, Neuromuscular Disorder, Periodic Paralysis


name: IVD Panels, Human Genetics, Vascular Malformation, Cerebral Cavernous


name: IVD Panels, Human Genetics, Mitochondrial Disorder, Primary Coenzyme Q10 Deficiency


name: IVD Panels, Human Genetics, Blood Disorder, Thrombotic Microangiopathy


name: IVD Panels, Human Genetics, Connective Tissue Disorder, Cutis Laxa


name: IVD Panels, Human Genetics, Encephalopathy, Brain Malformation, Holoprosencephaly


name: IVD Panels, Human Genetics, Neuromuscular Disorder, Collagen VI-Related Myopathy


name: IVD Panels, Human Genetics, Metal Accumulation, Copper/Iron, Mutation


name: Intravenous Poles, Free-Standing, Lift-Assistance


name: IVD Panels, Human Genetics, Pancreatic Disorder, Pancreatitis


name: Surgical Drapes, Patient, Disposable, Abdominal Procedure


name: Masks, Air-Oxygen, Positive Airway Pressure Unit


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Oral


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Total Face


name: Masks, Air-Oxygen, Non-Invasive Positive Pressure Ventilator


name: Procedure Kit/Trays, Irrigation/Lavage, Ostomy


name: Software, Information System, Healthcare Facility, Administrative, Internet of Things Security


name: IVD Panels, Human Genetics, Metabolic Disorder, Metal Accumulation, Comprehensive, Mutation


name: IVD Panels, Human Genetics, Pancreatitis


name: IVD Test Reagent/Kits, Multimodal Assay, Chromosome Anomaly/Gene Anomaly


name: IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, PIK3CA


name: IVD Test Reagent/Kits, Mass Spectrometry, Preeclampsia


name: Hemostatic Agents, Surgical, Oxidized Regenerated Cellulose


name: Hemostatic Agents, Surgical, Polysaccharide Spheres


name: Hemostatic Agents, Surgical, Thrombin-Containing


name: Interbody Spinal Fusion Implants, Cervical


name: Paragangliomas 3 (PGL3) Gene Anomaly Detection


name: Medicare Chronic Condition Special Needs Plan (C-SNP)


name: Medicare Institutional Special Needs Plan (I-SNP)


name: Dual Eligible Special Needs Plan (D-SNP)


name: Fully Integrated Dual Eligible Special Needs Plan (FIDE-SNP)


name: ReliOn Premier Classic Blood Glucose Monitoring System


name: Gel, Multi Ingredient Topical application Pad [SCARCIN PAD]


name: Medical Food Oral Powder for Suspension [PKU EXPLORE5]


name: Medical Food Oral Powder for Suspension [PKU EXPLORE10]


name: Electrolytes Oral Solution [ORALYTE PEDIATRIC ELECTROLYTE]


name: Solution, Multi Ingredient Topical application Solution [CLEAN & CLEAR LEMON JUICE TONER]


name: Cleanser Topical application Pad [LEADER BABY WIPES]


name: Ascorbic Acid/Calcium/Cholecalciferol/Ferrous Gluconate/Folic Acid/Methylcobalamin/Potassium Iodide/Pyridoxal Phosphate/Thiamine Hydrochloride 125 MG-200 MG-12.5 MCG-13 MG-1 MG-1000 MCG-150 MCG-2.5 MG-1.4 MG Oral Tablet


name: 5-Methyltetrahydrofolate Calcium/alpha Tocopherol/Ascorbic Acid/Beta Carotene/Biotin/Calcium Carbonate/Cholecalciferol/Cyanocobalamin/Ferrous Bisglycinate Chelate/Folic Acid/Magnesium Oxide/Potassium Iodide/Pyridoxine Hydrochloride 1 MG-4.5 MG-60 MG-300 MCG-0.28 MG-80 MG-10 MCG-0.013 MG-20 MG-0.67 MG-25 MG-0.15 MG-26 MG Oral Tablet


name: SECNIDAZOLE 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 90 mg in 1 mL / Homosalate 1000 mg in 1 mL / OCTISALATE 202.5 mg in 1 mL / OCTOCRYLENE 640 mg in 1 mL TOPICAL LOTION [baby]


name: AVOBENZONE 90 mg in 1 mL / Homosalate 1000 mg in 1 mL / OCTISALATE 202.5 mg in 1 mL / OCTOCRYLENE 640 mg in 1 mL TOPICAL Lotion [Sunscreen]


name: HOMOSALATE 4.2 g in 28 mL / OCTISALATE 1.4 g in 28 mL / OCTOCRYLENE 2.8 g in 28 mL / AVOBENZONE 0.84 g in 28 mL TOPICAL SPRAY [SnugZ SPF 50 Sunscreen Spry]


name: AVOBENZONE 26.55 mg in 1 mL / HOMOSALATE 88.5 mg in 1 mL / OCTISALATE 44.25 mg in 1 mL / OCTOCRYLENE 44.25 mg in 1 mL TOPICAL SPRAY [Pamana Jack Kids Broad Spectrum SPF 50]


name: AVOBENZONE 29.73 mg in 1 mL / OCTISALATE 49.55 mg in 1 mL / OCTOCRYLENE 49.55 mg in 1 mL / HOMOSALATE 99.1 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 50]


name: AVOBENZONE 29.97 mg in 1 mL / OCTISALATE 49.95 mg in 1 mL / OCTOCRYLENE 99.9 mg in 1 mL / HOMOSALATE 149.85 mg in 1 mL TOPICAL LOTION [Panama Jack Broad Spectrum SPF 100]


name: OCTINOXATE 30 mg in 1 mL / TITANIUM DIOXIDE 17.5 mg in 1 mL TOPICAL CREAM [TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 N203]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL CREAM [Exuviance Daily Corrector with Sunsreen Broad Spectrum SPF 35]


name: TITANIUM DIOXIDE 70 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL LOTION [Exuviance Skin Caring BB Fluid with Sunscreen Broad Spectrum SPF 50]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [Aveeno Kids Continuous Protection Sensitive Skin Mineral Sunscreen Broad Spectrum SPF 50]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [Neutrogena Sheer Zinc Kids Mineral Sunscreen Broad Spectrum SPF 50 Plus]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Axe]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20 g in 100 g TOPICAL STICK [Suave]


name: AVOBENZONE 30 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL CREAM [Exuviance Age Reverse Day Repair with Sunscreen Broad Spectrum SPF 30]


name: OCTOCRYLENE 16.72 mg in 1 mL TOPICAL OIL [Panama Jack SPF 4 Dark Tanning Oil]


name: OCTOCRYLENE 19.12 mg in 1 mL TOPICAL LOTION [Panama Jack SPF 4]


name: Ketoconazole;Miconazole Nitrate 2%; 2% Topical application Kit [PEDIZOLPAK]


name: AVOBENZONE 90 mg in 1 mL / Homosalate 1000 mg in 1 mL / OCTISALATE 250 mg in 1 mL / OCTOCRYLENE 360 mg in 1 mL TOPICAL Lotion [Sunscreen]


name: LIDOCAINE HYDROCHLORIDE 10 mg in 1 mL TOPICAL LIQUID [NATURES CRAFT LIDOCAINE Male Genital Desensitizer]


name: AVOBENZONE 25 mg in 1 mL / HOMOSALATE 60 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF30]


name: AVOBENZONE 25 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Neutrogena Clear Body Breakout Free Oil Free Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL SPRAY [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Stick Broad Spectrum SPF 50 Plus]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF45]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF55]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL SPRAY [Neutrogena Ultra Sheer Face Mist Sunscreen Broad Spectrum SPF 55]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 45 mg in 1 mL / OXYBENZONE 40 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 70]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF50]


name: OCTISALATE 20 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Up and Up Illuminating Daily Moisturizer with Sunscreen Broad Spectrum SPF 15]


name: OCTISALATE 50 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OXYBENZONE 60 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Equate Beauty Ultra Light SPF 100]


name: Avobenzone 10 mg in 1 mL / Homosalate 45 mg in 1 mL / Octinoxate 75 mg in 1 mL / Octisalate 45 mg in 1 mL / Oxybenzone 30 mg in 1 mL TOPICAL CREAM [Cicatricure Brightening Face With SPF]


name: Avobenzone 20 mg in 1 g / Homosalate 50 mg in 1 g / Octisalate 44 mg in 1 g / Octocrylene 90 mg in 1 g TOPICAL CREAM [Cicatricure Aqua Defense Day With SPF]


name: Octinoxate 6.5 g in 30 g / TITANIUM DIOXIDE 4.25 g in 30 g / OCTISALATE 5 g in 30 g TOPICAL CREAM [No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Cool Beige]


name: Octinoxate 6.5 g in 30 g / TITANIUM DIOXIDE 4.25 g in 30 g / OCTISALATE 5 g in 30 g TOPICAL CREAM [No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Ivory]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL TOPICAL SPRAY [SPF 30 Scalp and Hair Mist]


name: HOMOSALATE 70 mg in 1 mL / OXYBENZONE 40 mg in 1 mL / AVOBENZONE 20 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL TOPICAL LOTION [HEB Solutions Sunscreen Ultra 30]


name: OCTOCRYLENE 40 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL AEROSOL, SPRAY [Up and Up Sport Sunscreen Broad Spectrum SPF 50]


name: Octinoxate 6.5 g in 30 g / TITANIUM DIOXIDE 4.25 g in 30 g / OCTISALATE 5 g in 30 g TOPICAL CREAM [No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Beige]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 30 mg in 1 g / OXYBENZONE 30 mg in 1 g TOPICAL STICK [Softlips Vanilla Watermelon]


name: TITANIUM DIOXIDE 0.032 g in 1 mL / ZINC OXIDE 0.077 g in 1 mL TOPICAL CREAM [RECHARGE Protect Blur]


name: HOMOSALATE 100 mg in 1 g / OXYBENZONE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Equate SPF 50 Sport Sunscreen]


name: ZINC OXIDE 216 mg in 1 mL TOPICAL LOTION [Neutrogena Sheer Zinc Kids Mineral Sunscreen Broad Spectrum SPF 50 Plus]


name: Octinoxate 6.5 g in 30 g / TITANIUM DIOXIDE 4.25 g in 30 g / OCTISALATE 5 g in 30 g TOPICAL CREAM [No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Calico]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Secret with Essential Oils Rose and Charcoal Invisible]


name: ZINC OXIDE 20.2 g in 100 g TOPICAL CREAM [Kerstin Florian Multi-Vitamin Day Creme SPF 30]


name: HOMOSALATE 7 g in 100 g / OCTOCRYLENE 5 g in 100 g / AVOBENZONE 2 g in 100 g TOPICAL SPRAY [BANANA BOAT]


name: Octinoxate 6.5 g in 30 g / TITANIUM DIOXIDE 4.25 g in 30 g / OCTISALATE 5 g in 30 g TOPICAL CREAM [No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Chestnut]


name: CLENBUTEROL HYDROCHLORIDE 100 g in 100 g POWDER


name: ISOPROTERENOL HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: TRAMETINIB 1 g in 1 g NOT APPLICABLE POWDER


name: TRILOSTANE 100 g in 100 g NOT APPLICABLE POWDER


name: AVOBENZONE 1.285 g in 50 mL / OCTINOXATE 3.8036 g in 50 mL / OCTOCRYLENE 1.542 g in 50 mL TOPICAL EMULSION [SHISEIDO WHITE LUCENT DAY]


name: TITANIUM DIOXIDE 2 g in 100 g / ZINC OXIDE 18.4 g in 100 g TOPICAL CREAM [NELLY DEVUYST ORGANIC TRANSPARENT MINERAL SUNSCREEN SPF30]


name: OCTISALATE 30 mg in 1 mL / OCTOCRYLENE 20 mg in 1 mL / AVOBENZONE 20 mg in 1 mL TOPICAL CREAM [YANBAL SENTIVA EXTRACTO DIVINO YOUTH RENEWAL MOISTURIZING SPF 20]


name: Diclofenac Sodium 3% Topical application Gel/Jelly [SOLARAVIX]


name: TELMISARTAN 1 g in 1 g NOT APPLICABLE POWDER


name: CHLORAMPHENICOL PALMITATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: CLEMASTINE FUMARATE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 60 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OXYBENZONE 35 mg in 1 mL TOPICAL CREAM [BB SPF20]


name: OCTISALATE 0.05 g in 1 g / OXYBENZONE 0.06 g in 1 g / HOMOSALATE 0.05 g in 1 g / OCTINOXATE 0.075 g in 1 g / AVOBENZONE 0.01 g in 1 g TOPICAL LOTION [Scrubs Sunscreen]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 13]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 21]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 31]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Leader General Protection SPF 30 Sunscreen]


name: TITANIUM DIOXIDE 0.042 g in 1 g / ZINC OXIDE 0.07 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB SPF42 No23]


name: OCTINOXATE 30 mg in 1 mL / TITANIUM DIOXIDE 17.5 mg in 1 mL TOPICAL CREAM [TEINT COUTURE CITY BALM - Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25 N200]


name: AVOBENZONE 20 mg in 1 g / HOMOSALATE 40 mg in 1 g / OCTISALATE 40 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL GEL [Neutrogena Hydro Boost City Shield water Broad Spectrum SPF 25]


name: {56 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack [Trikafta (100 MG / 50 MG / 75 MG; 150 MG)]


name: {30 (24 HR amantadine 129 MG Extended Release Oral Tablet [Osmolex]) / 30 (24 HR amantadine 193 MG Extended Release Oral Tablet [Osmolex]) } Pack [Osmolex 322 MG Daily Dosing]


name: selenium sulfide micronized 52 % to 55.5 % MISCELL POWDER (GRAM)


name: diluent for lefamulin(10mM citrate buffered 0.9 % sod chlor) INTRAVEN PLASTIC BAG, INJECTION (ML)


name: folic acid and methyltetrahydrofolate calcium


name: parenteral electrolytes combination no.31


name: parenteral electrolytes combination no.32


name: parenteral electrolytes combination no.33


name: diluent for dengue vacc, vero cell 0.4 % sod chlor


name: diluent for lefamulin (10mM citrate 0.9 % sod chl)


name: {56 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack


name: {30 (24 HR amantadine 129 MG Extended Release Oral Tablet) / 30 (24 HR amantadine 193 MG Extended Release Oral Tablet) } Pack


name: hard maple pollen extract / red maple pollen extract


name: California black walnut pollen extract / English walnut pollen extract


name: oneseed juniper pollen extract / Rocky Mountain juniper pollen extract


name: CATHETER,INTERMITTENT COUDE 14FR COLOPLAST #20024


name: CATHETER,SUCTION 10FR MAXIFLO SMITHS #640010


name: CLEANSING CLOTH,ALOETOUCH PKT M#MSC095228


name: BANDAGE TUBULAR ELASTIC 4IN X 11YD SAG13115


name: DRESSING,ALLEVYN GENTLE BORDER LITE 7.5CM X 7.5CM #66020412


name: DRESSING,COLACTIVE PLUS AG 4IN X 4IN #10340000


name: DRESSING,CUTIMED SORBION SORBACT 4IN X 4IN #7269808


name: DRESSING,CUTIMED SORBION SORBACT 8IN X 12IN #7269811


name: DRESSING,HYDROFERA BLUE HEAVY DRAINAGE 6IN X 6IN HBHD6675


name: DRESSING,OPTIFOAM NON-ADHESIVE 3IN X 3IN #MSC1133F


name: DRESSING,POLYMEM MAX 3.5IN X 3.5IN,FERRIS #606


name: HEAT & MOISTURE EXCHANGER,BLOM-SINGER HME BE1055EZ


name: KIT PREP OF TECHNETUM TC-99 OXIDRONATE SODIUM INJ


name: KIT PREP OF TECHNETUM TC-99 TILMANOCEPT INJ


name: SALIVA,ARTIFICIAL (GC DRY MOUTH) GEL,DENT


name: Leader Pediatric Electrolyte Solution (Bubblegum)


name: Leader Pediatric Electrolyte Solution (Grape)


name: Leader Pediatric Electrolyte Solution (Strawberry)


name: OMRON MICRO Air Vibrating Mesh Nebulizer


name: Pedialyte Sparkling RUSH Electrolyte Powder for Solution (Cherry)


name: Pedialyte Sparkling RUSH Electrolyte Powder for Solution (Grape)


name: ReliOn Premier BLU Blood Glucose Monitoring System


name: ReliOn Premier Compact Blood Glucose Monitoring System


name: ReliOn Premier Voice Blood Glucose Monitoring System


name: Glytactin RTD LITE 15PE Suspension (Coffee Mocha)


name: Glytactin RTD LITE 15PE Suspension (Vanilla)


name: Cellpad Medical Grade Silicone Gel Matrix


name: Discount Drug Mart Pentips Plus Pen Needles,


name: Blink RevitaLens Multi-Purpose Disinfecting S


name: Cream, Multi Ingredient Topical application Cream [LEADER MINERIN CREME]


name: AMINOCAPROIC ACID 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 16.44 mg in 1 mL / OCTISALATE 41.1 mg in 1 mL / OCTOCRYLENE 16.44 mg in 1 mL TOPICAL SPRAY [Australian Gold Broad Spectrum SPF 15]


name: AVOBENZONE 16.98 mg in 1 mL / OCTISALATE 42.45 mg in 1 mL / OCTOCRYLENE 16.98 mg in 1 mL TOPICAL SPRAY [Australian Gold Instant Bronzer Broad Spectrum SPF 15]


name: AVOBENZONE 19.6 mg in 1 mL / OCTISALATE 49 mg in 1 mL / OCTOCRYLENE 19.6 mg in 1 mL TOPICAL SPRAY [Australian Gold SPF 15 Sunscreen]


name: AVOBENZONE 25.38 mg in 1 mL / HOMOSALATE 63.45 mg in 1 mL / OCTISALATE 42.3 mg in 1 mL / OCTOCRYLENE 42.3 mg in 1 mL TOPICAL SPRAY [Australian Gold Broad Spectrum SPF 30]


name: AVOBENZONE 9.35 mg in 1 mL / OCTOCRYLENE 18.7 mg in 1 mL / OCTISALATE 28.05 mg in 1 mL TOPICAL SPRAY [Australian Gold Instant Bronzer SPF 8 Sunscreen]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OXYBENZONE 30 mg in 1 g TOPICAL STICK [Neutrogena Wet Skin Kids Beach and Pool Sunscreen Broad Spectrum SPF 70 Plus]


name: Avobenzone 30 mg in 1 g / Octisalate 50 mg in 1 g / Octocrylene 70 mg in 1 g TOPICAL CREAM [Lancome Paris Renergie Lift MultiAction Ultra Lifting Firming Dark Spot Correcting Broad Spectrum SPF 30 Sunscreen]


name: OCTINOXATE 75 mg in 1 mL / TITANIUM DIOXIDE 32 mg in 1 mL TOPICAL LIQUID [Lancome Paris Renergie Lift Makeup Broad Spectrum SPF 27 Sunscreen]


name: OCTINOXATE 75 mg in 1 mL TOPICAL LIQUID [Lancome Paris Renergie Lift Makeup Broad Spectrum SPF 26 Sunscreen]


name: OXYBENZONE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / HOMOSALATE 130 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [Leader Baby SPF 50]


name: OCTINOXATE 75 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL LIPSTICK [Neutrogena Revitalizing Lip Balm SPF 20 - Fresh Plum 60]


name: TITANIUM DIOXIDE 2.05 mg in 50 mL / ZINC OXIDE 5.75 mg in 50 mL TOPICAL CREAM [Dr.Jart Every Sun Day Mineral Sun Screen]


name: ZINC OXIDE 240 mg in 1 mL TOPICAL LOTION [MUSTELA MINERAL SUNSCREEN BROAD SPECTRUM SPF 50]


name: BASIC FIBROBLAST GROWTH FACTOR (HUMAN) 0.001 g in 100 mL TOPICAL LIQUID [Oliglo Multi-Action Peptide Gel Pack]


name: GREEN TEA LEAF 1.2 g in 100 mL TOPICAL LIQUID [Oliglo Lifting Serum]


name: HOMOSALATE 50 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OXYBENZONE 20 mg in 1 mL / TITANIUM DIOXIDE 29 mg in 1 mL TOPICAL LOTION [Neutrogena Healthy Skin Radiant Tinted Moisturizer Sunscreen Broad Spectrum SPF 30, Sheer Fair 20]


name: TITANIUM DIOXIDE 15 g in 100 g / ZINC OXIDE 10 g in 100 g TOPICAL POWDER [Super BB Beauty Balm Powder SPF 30]


name: TITANIUM DIOXIDE 57.6 mg in 1 mL / ZINC OXIDE 29.4 mg in 1 mL TOPICAL CREAM [Super BB Beauty Balm Cream SPF 30]


name: AVOBENZONE 27 mg in 1 mL / HOMOSALATE 40 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL / OXYBENZONE 45 mg in 1 mL TOPICAL LOTION [Neutrogena Clear Face Breakout Free Oil Free Broad Spectrum SPF 55]


name: Titanium Dioxide 85.4 mg in 1 mL / Zinc Oxide 40.7 mg in 1 mL TOPICAL CREAM [TiZO2]


name: ZINC OXIDE 25 g in 100 g TOPICAL CREAM [Bali Bloc SPF 30 Cocoa Sunscreen]


name: OCTINOXATE 562 mg in 1 g / OCTISALATE 250 mg in 1 g / ZINC OXIDE 1000 mg in 1 g / OCTOCRYLENE 1000 mg in 1 g TOPICAL CREAM [Sunscreen]


name: TITANIUM DIOXIDE 15 g in 100 g / ZINC OXIDE 10 g in 100 g TOPICAL POWDER [Mineral Wear Airbrushing Pressed Powder]


name: ZINC OXIDE 25 g in 100 g TOPICAL CREAM [Green Screen SPF 31 Bronze Sunscreen]


name: AVOBENZONE 90 mg in 1 g / HOMOSALATE 225 mg in 1 g / OCTISALATE 250 mg in 1 g / OCTOCRYLENE 1000 mg in 1 g TOPICAL SPRAY [Sunscreen]


name: TITANIUM DIOXIDE 6.388 mg in 40 mL / OCTINOXATE 1.996 mg in 40 mL / OCTISALATE 1.2 mg in 40 mL TOPICAL CREAM [Dr.Jart Dis-A-Pore Beauty Balm 01]


name: TITANIUM DIOXIDE 6.388 mg in 40 mL / OCTINOXATE 1.996 mg in 40 mL / OCTISALATE 1.2 mg in 40 mL TOPICAL CREAM [Dr.Jart Dis-A-Pore Beauty Balm 02]


name: TITANIUM DIOXIDE 10 mg in 1 mL / ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [ZO Skin Health Sunscreen Plus Primer Broad-Spectrum SPF 30]


name: CIPROFLOXACIN HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: Benzalkonium Chloride;Lidocaine/Prilocaine 0.13%; 2.5%-2.5% Topical application Kit [MICROVIX LP]


name: Zinc Oxide 200 mg in 1 g TOPICAL CREAM [CoTZ Flawless Complexion]


name: Zinc Oxide 200 mg in 1 g TOPICAL CREAM [TiZO Ultra Zinc SPF 40 (Tinted)]


name: OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [Hand Screen Broad Spectrum Sunscreen SPF 40]


name: DICLAZURIL 1 g in 1 g NOT APPLICABLE POWDER


name: IDOXURIDINE 1 g in 1 g NOT APPLICABLE POWDER


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 12.8 g in 64 g TOPICAL STICK [Mossy Oak Eclipse]


name: OCTINOXATE 1.6611 g in 30 mL / TITANIUM DIOXIDE 0.8475 mg in 30 mL TOPICAL EMULSION [CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION O70]


name: OCTOCRYLENE 2 g in 100 g / AVOBENZONE 1 g in 100 g TOPICAL LOTION [Hawaiian Tropic Island Tanning Sunscreen Cocoa Butter SPF 4]


name: OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [AMBI SKINCARE Even and Clear Daily Facial Moisturizer SPF 30]


name: Octinoxate 75 mg in 1 g / Octisalate 50 mg in 1 g / Oxybenzone 30 mg in 1 g / Titanium Dioxide 67.4 mg in 1 g TOPICAL CREAM [COVER plus CORRECT/TINTED MOISTURIZER CC CRM FAIR]


name: ZINC OXIDE 7.395 g in 100 g / OCTISALATE 4.5 g in 100 g / HOMOSALATE 9 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL LOTION [Banana Boat simply protect sensitive faces Mineral Enriched Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 15 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 8 g in 100 g TOPICAL SPRAY [TRADER JOES SUNSCREEN SPF 50]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 7 g in 100 mL TOPICAL LOTION [TRADER JOES FACE AND BODY SUNSCREEN SPF 30]


name: OCTINOXATE 0.05 g in 1 g / ZINC OXIDE 0.042 g in 1 g TOPICAL CREAM [ESIKA PRO NATURAL MATTE MATTIFYING FOUNDATION ADAPTABLE TO YOUR SKIN TONE SPF 20 Claro 1/Beige]


name: OCTINOXATE 0.05 g in 1 g / ZINC OXIDE 0.042 g in 1 g TOPICAL CREAM [ESIKA PRO NATURAL MATTE MATTIFYING FOUNDATION ADAPTABLE TO YOUR SKIN TONE SPF 20 Claro 2/Beige]


name: OCTINOXATE 0.05 g in 1 g / ZINC OXIDE 0.042 g in 1 g TOPICAL CREAM [ESIKA PRO NATURAL MATTE MATTIFYING FOUNDATION ADAPTABLE TO YOUR SKIN TONE SPF 20 Medio1/Beige]


name: OCTINOXATE 0.05 g in 1 g / ZINC OXIDE 0.042 g in 1 g TOPICAL CREAM [ESIKA PRO NATURAL MATTE MATTIFYING FOUNDATION ADAPTABLE TO YOUR SKIN TONE SPF 20 Medio2/Beige]


name: OCTINOXATE 0.05 g in 1 g / ZINC OXIDE 0.042 g in 1 g TOPICAL CREAM [ESIKA PRO NATURAL MATTE MATTIFYING FOUNDATION ADAPTABLE TO YOUR SKIN TONE SPF 20 Medio3/Beige]


name: OCTINOXATE 0.05 g in 1 g / ZINC OXIDE 0.042 g in 1 g TOPICAL CREAM [ESIKA PRO NATURAL MATTE MATTIFYING FOUNDATION ADAPTABLE TO YOUR SKIN TONE SPF 20 Medio4/Beige]


name: OCTINOXATE 0.05 g in 1 g / ZINC OXIDE 0.042 g in 1 g TOPICAL CREAM [ESIKA PRO NATURAL MATTE MATTIFYING FOUNDATION ADAPTABLE TO YOUR SKIN TONE SPF 20 Medio5/Beige]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 1/Beige]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 2/ Beige]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 3/ Beige]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 4/ Beige]


name: ALUMINUM SESQUICHLOROHYDRATE 0.16 g in 1 mL TOPICAL EMULSION [ESIKA TOTAL SEC NEUTRAL FRAGRANCE ANTIPERSPIRANT AND DEODORANT ALL DAY EXTRA EFFECTIVE PROTECTION]


name: Zinc Oxide 200 mg in 1 g TOPICAL CREAM [CoTZ Baby]


name: AVOBENZONE 90 mg in 1 mL / HOMOSALATE 1000 min in 1 mL / OCTISALATE 202.5 mg in 1 mL / OCTOCRYLENE 640 mg in 1 mL TOPICAL LOTION [Sunscreen]


name: OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 6 g in 100 g / HOMOSALATE 7 g in 100 g / AVOBENZONE 2.7 g in 100 g TOPICAL OIL [Hawaiian Tropic Island Tanning Broad Spectrum SPF 25]


name: Zinc Oxide 200 mg in 1 g TOPICAL CREAM [CoTZ Sensitive]


name: LIDOCAINE 10 mg in 1 mL TOPICAL OINTMENT [Prolayed Lidocaine Male Genital Desensitizer]


name: OCTOCRYLENE 6.5 g in 100 g / AVOBENZONE 2.7 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [Banana Boat Ultra Sport Sunscreen Broad Spectrum SPF 50]


name: LOSARTAN POTASSIUM 1 g in 1 g NOT APPLICABLE POWDER


name: ALUMINUM CHLOROHYDRATE 23.5 g in 100 g TOPICAL AEROSOL, SPRAY [Secret Dry Waterlily]


name: OCTINOXATE 7 g in 100 g / TITANIUM DIOXIDE 7.6 g in 100 g / ZINC OXIDE 3.6 g in 100 g TOPICAL CREAM [TOM FORD SHADE AND ILLUMINATE FOUNDATION BROAD SPECTRUM SPF 45 SOFT RADIANCE CUSHION COMPACT REFILL]


name: OCTOCRYLENE 3 g in 100 g / OXYBENZONE 4 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL SPRAY [Hawaiian Tropic Silk Hydration Clear Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 90 mg in 1 mL / HOMOSALATE 2250 mg in 1 mL / Octisalate 250 mg in 1 mL / OCTOCRYLENE 1000 mg in 1 mL TOPICAL lotion [SUNSCREEN]


name: PETROLATUM 86 mg in 1 g TOPICAL OINTMENT [Resurfix Plus]


name: Avobenzone 90 g in 1 g / Homosalate 2250 g in 1 g / Octisalate 250 g in 1 g / Octocrylene 640 g in 1 g TOPICAL SPRAY [sunscreen]


name: infant form.iron, lact.reduced/dha/arachidonic acid (ara) 2.2 gram-5.3 gram-10.9 gram/100 kcal ORAL POWDER (GRAM)


name: syringe with needle,insulin,0.5 mL 32 gauge X 5/16" MISCELL SYRINGE, EMPTY DISPOSABLE


name: nutritional therapy, glucose intolerance,soy 10 gram-160 kcal/40 gram ORAL BAR


name: fluconazole/ibuprofen/itraconazole/terbinafine HCl 4 %-2 %-1 %-4 % TOPICAL SOLUTION (GRAM)


name: AEROSOL POWDER, BREATH ACTIV WITH SENSOR


name: allantoin / benzocaine / camphor / dimethicone / menthol / petrolatum


name: PROSOURCE GELATEIN PLUS PINEAPPLE GEL,ORAL


name: CATHETER,INTERMITTENT 18FR LOFRIC HYDRO-KIT #4201840


name: CATHETER,INTERMITTENT COUDE 12FR LOFRIC PRIMO #4151240


name: CATHETER,INTERMITTENT,GENTLECATH 16FR FEMALE #501023


name: FEEDING BAG W/PUMP SET ENFIT COVIDIEN #772055


name: PRONTOSAN WOUND IRRIGATION BRAUN #400441


name: Medical Dictionary for Regulatory Activities Terminology (MedDRA), Korean Edition


name: Regurgitant blood flow pressure half-time


name: Gene product metabolic activity interpretation


name: IRF-PAI v3.0, LCDS v4.00, OASIS E - Health conditions - discharge or expired or transfer


name: LCDS v4.00 - Signs and Symptoms of Delirium (from CAM)


name: LCDS v4.00 - Self-care - discharge performance


name: LCDS v3.00 - Bladder and bowel - planned discharge


name: LCDS v4.00 - Self-care - admission performance


name: LCDS v4.00 - Skin conditions - discharge


name: LCDS v4.00 - Spontaneous breathing trial


name: MDS v3.0 - RAI v1.17.2 - Optional state assessment


name: Outcome and assessment information set (OASIS) form - version D1:-:Pt:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1


name: OASIS D1 - Patient history and diagnoses - follow-up:-:Pt:^Patient:-:CMS Assessment


name: OASIS D1 - Patient history and diagnoses - follow-up


name: OASIS D1 - ADL and IADLs - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up:-:Pt:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken


name: Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby


name: Other things you are feeling bothered, upset or worried about:Find:Pt:^Patient:Nom:NuPDQ


name: Other things you are feeling bothered, upset or worried about


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches


name: Physical symptom of pregnancy that you are feeling bothered, upset or worried about:Find:Pt:^Patient:Nom:NuPDQ


name: Physical symptom of pregnancy that you are feeling bothered, upset or worried about


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby


name: Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby:Find:Pt:^Patient:Nom:NuPDQ


name: Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes


name: Revised Prenatal Distress Questionnaire - Concurrent Self-Administered Version:-:Pt:^Patient:-:NuPDQ


name: Revised Prenatal Distress Questionnaire - Concurrent Self-Administered Version


name: Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form:-:Pt:^Patient:-:NuMoM2b


name: Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form


name: Quality of Working Life Questionnaire for Cancer Survivors:-:4W:^Patient:-:QWLQ-CS


name: Quality of Working Life Questionnaire for Cancer Survivors


name: During the past 4W, working gives me structure in my life:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, working gives me structure in my life


name: During the past 4W, I think it is good to work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I think it is good to work


name: During the past 4W, I consider that my work gives me a goal in life:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider that my work gives me a goal in life


name: During the past 4W, I consider my work important:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider my work important


name: During the past 4W, I do my work well:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am self-confident in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am self-confident in my work


name: During the past 4W, I am suited to my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am suited to my work


name: During the past 4W, I have control over the work I do:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have control over the work I do


name: During the past 4W, I feel powerless in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel powerless in my work


name: During the past 4W, I feel there is a positive atmosphere in my working environment:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel there is a positive atmosphere in my working environment


name: During the past 4W, I have the feeling I am taken seriously by people in my working environment:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have the feeling I am taken seriously by people in my working environment


name: During the past 4W, I am content with my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with my work


name: During the past 4W, I have good relations with my colleagues:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have good relations with my colleagues


name: During the past 4W, I feel valuable to my colleagues:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel valuable to my colleagues


name: During the past 4W, my immediate superior understands my health situation and possible health problems:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, my immediate superior understands my health situation and possible health problems


name: During the past 4W, I have good relations with my immediate superior:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have good relations with my immediate superior


name: During the past 4W, I consider that employees with health problems are treated well in my organization:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider that employees with health problems are treated well in my organization


name: During the past 4W, I am content with the fringe benefits provided by my employer:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with the fringe benefits provided by my employer


name: During the past 4W, I am content with my current income:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with my current income


name: During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy


name: During the past 4W, I am limited in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am limited in my work


name: During the past 4W, because of my health situation I have little trust in my own body:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I have little trust in my own body


name: During the past 4W, because of my health situation I feel uncertain about the future:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I feel uncertain about the future


name: Perception of your work situation:-:4W:^Patient:-:QWLQ-CS


name: Atmosphere in your working environment:-:4W:^Patient:-:QWLQ-CS


name: Understanding and recognition in your organization:-:4W:^Patient:-:QWLQ-CS


name: Understanding and recognition in your organization


name: Problems due to your health situation:-:4W:^Patient:-:QWLQ-CS


name: Difficulties in Pregnancy total score:Score:Pt:^Patient:Qn:NuMoM2b


name: Dark-mediated rod adaptation time:Time:Pt:Eye.right:Qn


name: Dark-mediated rod adaptation time:Time:Pt:Eye.left:Qn


name: New York Heart Association Functional Classification:-:Pt:^Patient:-:NYHA


name: New York Heart Association Functional Classification


name: Sit to stand^with use of upper extremities:NRat:30S:^Patient:Qn


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0:-:Pt:^Patient:-:CMS Assessment


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0


name: Bone development stage:Score:Pt:Upper extremity>Radius:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.trapezoid:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.trapezium:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.scaphoid:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.lunate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.triquetrum:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.hamate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.capitate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Thumb.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.middle phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.middle phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Thumb.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.fifth:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.third:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.first:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Ulna:Qn:XR


name: Drug classes that have an indication documented:Type:Pt:^Patient:Nom:CMS Assessment


name: Drug classes that have an indication documented


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication


name: How much of the time has pain made it hard for you to sleep at night:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy:Find:Pt:^Patient:Ord:SILS


name: How Often Need Help Reading Instructions, Pamphlets, or other Written Material from Doctor or Pharmacy


name: How often have you limited your day-to-day activities because of pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How often do you feel lonely or isolated from those around you:Find:Pt:^Patient:Ord:CMS Assessment


name: How often do you feel lonely or isolated from those around you


name: How often have you limited your participation in rehabilitation therapy sessions due to pain over:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: IRF-PAI v4.0 - Administrative information:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Administrative information


name: IRF-PAI v4.0 - Cognitive patterns - admission:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Cognitive patterns - admission


name: IRF-PAI v4.0 - Cognitive patterns - discharge:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Cognitive patterns - discharge


name: IRF-PAI v4.0 - Health conditions - admission:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Health conditions - admission


name: IRF-PAI v4.0 - Hearing, speech, and vision - admission:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Hearing, speech, and vision - admission


name: IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC


name: IRF-PAI v4.0 - Identification information:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Identification information


name: IRF-PAI v4.0, LCDS v5.00 - Medications - admission:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Medications - admission


name: IRF-PAI v4.0, LCDS v5.00 - Medications - discharge:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Medications - discharge


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood


name: IRF-PAI v4.0 - Quality indicators - admission:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Quality indicators - admission


name: IRF-PAI v4.0 - Quality indicators - discharge:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Quality indicators - discharge


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - admission:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - admission


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge


name: IRF-PAI v4.0 - Swallowing &or nutritional status - admission:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Swallowing &or nutritional status - admission


name: IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge:-:Pt:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge


name: IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired:-:Pt:^Patient:-:CMS Assessment